I'm not trying to deflate the balloon here with my comments on efficacy. The best thing to focus on at this point in the trial is the long-term safey. Patients are now clearing one year on apabetalone with no red flags. At this point in BETonMACE, this is twice the dosing length of any of the previous trials with apabetalone. This is great news!
BearDownAZ